We are live on ! Find out more
MAP

Moody Aldrich Partners Portfolio holdings

AUM $557M
1-Year Est. Return 122.79%
This Fund
S&P 500
This Quarter Est. Return
+14.15%
1 Year Est. Return
+122.79%
3 Year Est. Return
+335.86%
5 Year Est. Return
+437.05%
10 Year Est. Return
+2,951.39%
AUM
$144M
AUM Growth
+$22.6M
Cap. Flow
+$11.6M
Cap. Flow %
8.1%
Top 10 Hldgs %
21.53%
Holding
108
New
19
Increased
59
Reduced
16
Closed
14

Sector Composition

Rank Sector Weight
1 Technology 18.22%
2 Healthcare 13.67%
3 Financials 12.56%
4 Industrials 12.46%
5 Consumer Discretionary 11.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPSC icon
76
SPS Commerce
SPSC
$2.64B
$841K 0.59%
22,920
+3,040
+15% +$99.9K
TMH
77
DELISTED
Team Health Holdings Inc
TMH
$810K 0.56%
24,870
+2,375
+11% +$87.6K
HAIN icon
78
Hain Celestial
HAIN
$53.7M
$793K 0.55%
+22,285
New +$977K
TSRO
79
DELISTED
TESARO, Inc.
TSRO
$773K 0.54%
+7,710
New +$720K
LXRX icon
80
Lexicon Pharmaceuticals
LXRX
$1.1B
$762K 0.53%
+42,180
New +$679K
ICUI icon
81
ICU Medical
ICUI
$4.61B
$756K 0.53%
5,980
-5,235
-47% -$631K
FET icon
82
Forum Energy Technologies
FET
$835M
$747K 0.52%
+1,881
New +$647K
CLVS
83
DELISTED
Clovis Oncology, Inc.
CLVS
$747K 0.52%
+20,730
New +$445K
PBYI icon
84
Puma Biotechnology
PBYI
$454M
$745K 0.52%
+11,105
New +$562K
MOH icon
85
Molina Healthcare
MOH
$10.3B
$735K 0.51%
12,600
+1,320
+12% +$72.8K
SF
86
Stifel
SF
$12.6B
$698K 0.49%
+40,837
New +$656K
INSM icon
87
Insmed
INSM
$28.6B
$684K 0.48%
+47,130
New +$590K
EHC icon
88
Encompass Health
EHC
$12.4B
$676K 0.47%
20,942
+2,005
+11% +$65K
EXEL icon
89
Exelixis
EXEL
$13.4B
$634K 0.44%
+49,595
New +$536K
ACAD icon
90
Acadia Pharmaceuticals
ACAD
$5.03B
$608K 0.42%
+19,110
New +$648K
CBM
91
DELISTED
Cambrex Corporation
CBM
$375K 0.26%
8,440
-15,845
-65% -$771K
RARE icon
92
Ultragenyx Pharmaceutical
RARE
$2.55B
$321K 0.22%
+4,530
New +$289K
AOS icon
93
A.O. Smith
AOS
$8.7B
$244K 0.17%
4,932
-160
-3% -$7.47K
JKHY icon
94
Jack Henry & Associates
JKHY
$11.1B
$209K 0.15%
2,440
-75
-3% -$6.58K
ALGT icon
95
Allegiant Air
ALGT
$2.57B
-5,425
Closed -$822K
BLMN icon
96
Bloomin' Brands
BLMN
$937M
-58,660
Closed -$1.05M
CATY icon
97
Cathay General Bancorp
CATY
$4.24B
-78,450
Closed -$2.21M
ENOV icon
98
Enovis
ENOV
$1.53B
-17,578
Closed -$801K
FWRD icon
99
Forward Air
FWRD
$654M
-32,070
Closed -$1.43M
POR icon
100
Portland General Electric
POR
$5.77B
-22,700
Closed -$1M

Similar funds

Moody Aldrich Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Moody Aldrich Partners held 108 positions worth $144M, up 19% from $121M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Moody Aldrich Partners deployed $11.6M of net new capital in Q3 2016, opening 19 new positions and adding to 59 existing holdings. Its largest new stake was Gramercy Property Trust: 125,123 shares worth $3.62M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Dycom Industries, an estimated $1.24M trimmed.

  • Moody Aldrich Partners's largest Q3 2016 buy was Gramercy Property Trust: 125,123 shares worth $3.62M.
  • Moody Aldrich Partners added most to Silicon Laboratories in Q3 2016, an estimated $1.72M increase.
  • Moody Aldrich Partners's biggest Q3 2016 reduction was Dycom Industries, cutting an estimated $1.24M.
  • Moody Aldrich Partners fully exited Cathay General Bancorp in Q3 2016, selling an estimated $2.21M.
  • Moody Aldrich Partners's ten largest holdings make up 22% of its $144M portfolio in Q3 2016.
  • Moody Aldrich Partners opened 19 new positions and closed 14 in Q3 2016.
  • Moody Aldrich Partners's portfolio value rose 19% quarter-over-quarter to $144M.

Based on Moody Aldrich Partners's 13F filing for Q3 2016, filed 18 Oct 2016.